Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;332:1479 (24 June), doi:10.1136/bmj.38859.531354.7C (published 15 June 2006)
Walter O Inojosa, medical officer1, Inacio Augusto, laboratory technician1, Zeno Bisoffi, doctor in chief2, Teofile Josenado, director3, Paulo M Abel, medical coordinator1, August Stich, head of clinical tropical medicine4, Christopher J M Whitty, professor of international health5
1 CUAMM-Angola and Angotrip Project, Caritas, Luanda, Angola, 2 Centro per le Malattie Tropicali, Ospedale S Cuore, Negrar, Verona, Italy, 3 Instituto de Combate e Controlo das Tripanossomoiases, Ministério da Saúde, Luanda, 4 Department of Tropical Medicine and Epidemic Control, Medical Mission Institute, Würzburg, Germany, 5 Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London WC1B 3DP
Correspondence to: W O Inojosa, Universidade Católica de Moçambique Ponta Gêa Rua Marquês de Soveral, 960 CP 821, Beira, Mozambique inojosawalter{at}hotmail.com
Objective To assess the operational feasibility of detecting human African trypanosomiasis by active and passive case finding using the card agglutination test with serial dilution of serum to guide treatment.
Setting Trypanosomiasis control programme in the Negage focus, northern Angola, during a period of civil war.
Design Observational study.
Participants 359 patients presenting themselves to health centres with symptoms (passive case finding) and 14 446 people actively screened in villages.
Main outcome measures Whole blood and serological tests at different dilutions using the card agglutination test, and detection of parasites by microscopy.
Results Active case finding identified 251 people with a positive card agglutination test result, 10 of whom had confirmed parasites. In those presenting for investigation 34 of 51 with a positive card agglutination test result at the dilution of 1:8 or more used to guide treatment had parasites in blood, lymph node fluid, or cerebrospinal fluid, compared with 10 of 76 in those detected by active case finding: positive predictive values of 67% for passive case detection and 13% for active case detection. Only at a cut-off dilution more than 1:32 was the positive predictive value in active case detection reasonable (46%) and at this dilution 40% of microscopically proved cases were missed.
Conclusions The card agglutination test is useful for initial screening in active detection of cases with human African trypanosomiasis but, given the toxicity of the drugs, serology using the card agglutination test should be not used alone to guide treatment after active case finding. A second confirmatory test is needed.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati
Twitter What's this?